Filing Details

Accession Number:
0001179110-17-006289
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-28 17:27:43
Reporting Period:
2017-04-26
Filing Date:
2017-04-28
Accepted Time:
2017-04-28 17:27:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1695686 J Joseph Manning 100 Abbott Park Road
Abbott Park IL 60064
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2017-04-26 3,200 $26.70 26,224 No 4 M Direct
Common Shares Without Par Value Disposition 2017-04-26 200 $43.94 26,024 No 4 S Direct
Common Shares Without Par Value Disposition 2017-04-26 100 $43.94 25,924 No 4 S Direct
Common Shares Without Par Value Disposition 2017-04-26 100 $43.94 25,824 No 4 S Direct
Common Shares Without Par Value Disposition 2017-04-26 500 $43.95 25,324 No 4 S Direct
Common Shares Without Par Value Disposition 2017-04-26 2,300 $43.95 23,024 No 4 S Direct
Common Shares Without Par Value Disposition 2017-04-26 400 $43.97 22,624 No 4 S Direct
Common Shares Without Par Value Disposition 2017-04-26 600 $43.97 22,024 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2017-04-26 3,200 $0.00 3,200 $26.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-02-15 2018-02-14 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.